In clinical trials, patients treated with KALBITOR showed significant improvement in hereditary angloedema (HAE) attack symptoms at 4 hours.
KALBITOR is therapy that treats hereditary angioedema (HAE) attacks. It's the first and only under the skin (subcutaneous) treatment that targets plasma kallikrein.
Attend a live event and hear from someone with HAE. You can learn about his or her path to diagnosis and how they manage life with HAE.
FIND AN EVENT NEAR YOU ›
OnePath is here to support you throughout your treatment journey with KALBITOR.
LEARN MORE ›
What is the most important information I should know about KALBITOR?
Serious allergic reactions may happen in some people who receive KALBITOR. These allergic reactions can be life-threatening and usually happen within 1 hour after receiving KALBITOR.
Who should not receive KALBITOR?
Do not receive KALBITOR if you are allergic to KALBITOR. Before receiving KALBITOR, tell your doctor if you have ever had an allergic reaction to KALBITOR.
What else should I tell my doctor before I receive KALBITOR?
Tell your doctor if you are pregnant, plan to become pregnant, breast-feeding, or plan to breast-feed. It is not known if KALBITOR will harm your unborn baby or pass into your breast milk.
What are the possible side effects?
Common side effects of KALBITOR include headache, nausea, diarrhea, fever, injection site reactions, such as redness, rash, swelling, itching, or bruising, and stuffy nose. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Talk to your doctor for more information about your medical condition or treatment.